Direkt zum Inhalt
Merck

Xeno-immunogenicity of ice-free cryopreserved porcine leaflets.

The Journal of surgical research (2014-12-03)
Martina Seifert, Alexandra Bayrak, Meaghan Stolk, Naima Souidi, Maria Schneider, Ulrich A Stock, Kelvin G M Brockbank
ZUSAMMENFASSUNG

Undesirable processes of inflammation, calcification, or immune-mediated reactions are limiting factors in long-term survival of heart valves in patients. In this study, we target the modulatory effects of ice-free cryopreservation (IFC) of xenogeneic heart valve leaflet matrices, without decellularization, on the adaptive human immune responses in vitro. We tested porcine leaflet matrices from fresh untreated, conventionally cryopreserved (CFC), and IFC pulmonary valves by culturing them with human blood mononuclear cells for 5 d in vitro. No other tissue treatment protocols to modify possible immune responses were used. Matrices alone or in addition with a low-dose second stimulus were analyzed for induction of proliferation and cytokine release by flow cytometry-based techniques. Evaluation of the α-Gal epitope expression was performed by immunohistochemistry with fluorochrome-labeled B4 isolectin. None of the tested leaflet treatment groups directly triggered the proliferation of immune cells. But when tested in combination with a second trigger by anti-CD3, IFC valves showed significantly reduced proliferation of T cells, especially effector memory T cells, in comparison with fresh or CFC tissue. Moreover, the cytokine levels for interferon-γ (IFNγ), tumor necrosis factor α, and interleukin-10 were reduced for the IFC-treated group being significantly different compared with the CFC group. However, no difference between treatment groups in the expression of the α-Gal antigen was observed. IFC of xenogeneic tissue might be an appropriate treatment method or processing step to prevent responses of the adaptive immune system.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dimethylsulfoxid, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimethylsulfoxid, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, Molecular Biology
Sigma-Aldrich
Dimethylsulfoxid, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimethylsulfoxid, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimethylsulfoxid, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Dimethylsulfoxid, anhydrous, ≥99.9%
Sigma-Aldrich
2-Methylbutan, ReagentPlus®, ≥99%
Sigma-Aldrich
Saccharose, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Dimethylsulfoxid, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Saccharose, ≥99.5% (GC)
Sigma-Aldrich
Natriumazid, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Formamid, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Saccharose, ≥99.5% (GC), BioXtra
Sigma-Aldrich
Saccharose, BioUltra, Molecular Biology, ≥99.5% (HPLC)
Sigma-Aldrich
L-Glutamin, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
Propylenglycol, ≥99.5% (GC), FCC, FG
Sigma-Aldrich
Formamid, ≥99.5% (GC), BioReagent, Molecular Biology
Supelco
Saccharose, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutamin, ReagentPlus®, ≥99% (HPLC)
USP
Saccharose, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dimethylsulfoxid, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Natriumazid, BioUltra, ≥99.5% (T)
Sigma-Aldrich
Formamid, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
Saccharose, ≥99.5% (GC)
Sigma-Aldrich
Saccharose, ≥99.5% (GC), BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Propylenglykol, meets USP testing specifications
Sigma-Aldrich
Saccharose, ACS reagent
Millipore
Saccharose, ACS reagent, suitable for microbiology, ≥99.0%
SAFC
L-Glutamin